Dr. Michael Mulvey
 Michael Mulvey

Associate Professor, Department of Medical Microbiology and Infectious Diseases, University of Manitoba.

Adjunct Professor, Department of Medical Microbiology, University of Calgary.

Adjunct Professor, Department of Pathobiology,

University of Guelph Chief, Antimicrobial Resistance and Nosocomial Infections, National Microbiology Laboratory, Public Health Agency of Canada

Degrees: PhD (Manitoba, 1990) Academic Research Microbiologist 
 
Mailing Address: National Microbiology Laboratory, 1015 Arlington St. Winnipeg, Manitoba, R3E 3R2
 
Tel: (204) 789-2133, Fax: (204) 789-5020

E-mailMichael.mulvey@canada.ca

Twitter@superbugfighter

Research Interests:

Antimicrobial resistance and usage surveillance, molecular mechanisms and epidemiology of antimicrobial resistant organisms and linkages between epidemic strains, virulence, and antimicrobial resistance.

Recent Publications:

For a list of Dr. Mulvey's PubMed articles, please click here

Mulvey, M. R., I. Martin, T. Wong. Utilization of Nucleic Acid Amplification Testing Samples for Antimicrobial Resistance Surveillance in Remote Canadian Communities. Sexually Transmitted Diseases 2018; 45: p e61: doi: 10.1097/OLQ.0000000000000860.

Teatero, S., A. McGeer, G. J. Tyrrell, L. Hoang, H. Smadi, M.-C. Domingo, P. N. Levett, M. Finkelstein, K. Dewar, A. Plevneshi, T. B. T. Athey, J. B. Gubbay, M. R. Mulvey, I. Martin, W. Demczuk, and N. Fittipaldi. Canada-wide Epidemic of emm74 Group A Streptococcus Invasive Disease. Open Forum Infectious Diseases 2018; 5: ofy85.

MacNair, C. R., J. M. Stokes, L. A. Carfrae, M. R. Mulvey and E. D. Brown. Overcoming mcr-1 mediated colistin resistance with colistin. Nature Communications 2018; 9:458.

Lahra, M., I. Martin, W. Demczuk, A. Jennison, K.-I. Lee, S.-I. Nakayama, B. Lefebvre, J. Longtin, A. Ward, M. R. Mulvey, T. Wi, M. Ohnishi, D. Whiley. Cooperative recognition of the international dissemination of a ceftriaxone-resistant Neisseria gonorrhoeae strain. Emerging Infectious Diseases 2018; 4: DOI: 10.3201/eid2404.171873.

Golden, A. R., H. J. Adam, J. A. Karlowsky, M. Baxter, K. A. Nichol, I. Martin, W.  Demczuk, P. Van Caeseele, J. B. Gubbay, B. Lefebvre, G. Horsman, G. Zahariadis, D. Haldane, R. Gad, G. German, M. W. Gilmour, M. R. Mulvey, D. J. Hoban, G. G. Zhanel, on behalf of the Canadian Antimicrobial Resistance Alliance (CARA).  Molecular Characterization of Predominant Streptococcus pneumoniae Serotypes Causing Invasive Infections in Canada: The SAVE Study, 2011-2015. Journal of Antimicrobial Chemotherapy. 2018; 73: (suppl_7):vii20-vii31. doi: 10.1093/jac/dky157.

Adam, H. J., A. R. Golden, J. A. Karlowsky, M. R. Baxter, K. A. Nichol, I. Martin, W.  Demczuk, M. R. Mulvey, M. W. Gilmour, D. J. Hoban, G. G. Zhanel, on behalf of the Canadian Antimicrobial Resistance Alliance (CARA).  Analysis of Multidrug Resistance in the Predominant Streptococcus pneumoniae Serotypes in Canada: The SAVE Study, 2011-2015. Journal of Antimicrobial Chemotherapy. 2018; 73: (suppl_7):vii12-vii19. doi: 10.1093/jac/dky158.

Karlowsky, J. A., H. J. Adam, A. R. Golden, M. R. Baxter, K. A. Nichol, I. Martin, W.  Demczuk, M. R. Mulvey, M. W. Gilmour, D. J. Hoban, G. G. Zhanel, on behalf of the Canadian Antimicrobial Resistance Alliance (CARA).  Antimicrobial Susceptibility Testing of Invasive Isolates of Streptococcus pneumoniae from Canadian patients: The SAVE Study, 2011-2015. Journal of Antimicrobial Chemotherapy. 2018; 73: (suppl_7):vii5-vii11. doi: 10.1093/jac/dky156.

Chalmers, G., K. E. Davis , Z. Poljak , R. Friendship , M. R. Mulvey, A. E. Deckert, R. J. Reid-Smith , P. Boerlin. A method to detect Escherichia coli carrying the colistin- resistance genes mcr-1 and mcr-2 using a single real-time polymerase chain reaction and its application to chicken cecal and porcine fecal samples. The Canadian Veterinary Journal 2018; 4: 312-315.

Bogaty, C., L. Mataseje, A. Gray, B. Lefebvre, S. Levesque, M. R. Mulvey, Y. Longtin. Investigation of a Carbapenemase-producing Acinetobacter baumannii outbreak using whole genome sequencing versus a standard epidemiologic investigation.  Antimicrobial Resistance & Infection Control 2018; 7: 140.

Mulvey, M. R., A. Baharat, D. Boyd. R. Irwin, and J. Wylie. Characterization of a colistin-resistant Salmonella enterica 4,[5],12:i:- harboring mcr-3.2 on a variant IncHI-2 plasmid identified in Canada. Journal of Medical Microbiology 2018; doi: 10.1099/jmm.0.000854. [Epub ahead of print].
 
Vogt, N. A., D. L. Pearl, E. N. Taboada, S. K. Mutschall, N. Janecko, M. R. Mulvey, R. Reid-Smith, J. LeJeune, C. M. Jardine. A repeated cross-sectional study of the epidemiology of <i>Campylobacter</i> and antimicrobial resistant Enterobacteriaceae in free-living Canada geese in Guelph, Ontario, Canada. Zoonoses and Public Health 2018; doi: 10.1111/zph.12529. [Epub ahead of print].

Tyler, A. D., L. Mataseje, C. J. Urfano, L. Schmidt, K. S. Antonation, M. R. Mulvey, C. R. Corbett. Evaluation of Oxford Nanopore’s MinION Sequencing Device for Microbial Whole Genome Sequencing Applications. Scientific Reports 2018; 8:10931.

Ulah, U. V., M. Glass, B. Avery, D. Daignault, M. R. Mulvey, R. J. Reid-Smith, E. J. Parmley, A. Portt, P. Boerlin, A. R. Manges. Risk factors for acquisition of multidrug-resistant Escherichia coli and development of community-acquired urinary tract infections. Epidemiology & Infection 2018; 46: 46-57.

MacNair, C. R., J. M. Stokes, L. A. Carfrae, M. R. Mulvey and E. D. Brown. Overcoming mcr-1 mediated colistin resistance with colistin. Nature Communications 2018; 9:458.

Lisboa, L., L. Turnbull, D. Boyd, M. Mulvey, and T. Dingle.  Evaluation of modified carbapenem inactivation method for detection of carbapenemases in Pseudomonas aeruginosa. Journal of Clinical Microbiology 2017; 56: doi: 10.1128/JCM.01234-17.

Mataseje, L. D. Boyd, J. Fuller, D. Haldane, L. Hoang, B. Lefebvre, R. Melano, S. Poutanen, P. Van Caeseele, M. Mulvey. Characterization OXA-48-like carbapenemase producers in Canada, 2011-2014. Journal of Clinical Microbiology 2017; doi: 10.1093/jac/dkx462.

Mauffrey, F., É. Fournier, W. Demcuzuk, I. Martin, M. Mulvey, C. Martineau, S.  Lévesque, S. Bekal, M.-C. Domingo, F. Doualla-Bell, J. Longtin and B. Lefebvre. Comparison of sequential multiplex PCR, sequetyping and whole genome sequencing for serotyping of Streptococcus pneumoniae. PLoS One 2017; doi.org/10.1371/journal.pone.0189163.

Peterson, S. W., I. Martin, W. Demczuk, L. Hoang, J. Wylie, B. Lefebvre, A-C. Labbé, P. Naidu, D. Haldane, M. R. Mulvey. A comparison of Real-Time Polymerase Chain Reaction Assays for the Detection of Antimicrobial Resistance Markers and Sequence Typing from Clinical Nucleic Acid Amplification Test Samples and Matched Neisseria gonorrhoeae Culture. Sexually Transmitted Diseases 2017; 45: 92-95.

Mangat, C. S., S. Bekal, R. Irwin, and M. R. Mulvey. A novel hybrid plasmid carrying multiple antimicrobial resistance and virulence genes in Salmonella Dublin. Antimicrobial Agents and Chemotherapy.  2017; 61: pii: e02601-16. doi: 10.1128/AAC.02601-16.

Lagacé-Wiens, P., H. Adam, N. Laing, M. Baxter, I. Martin, M. Mulvey, J. Karlowsky, D. Hoban, G. G. Zhanel. Antimicrobial susceptibility of clinical isolates of Neisseria gonorrhoeae to alternative antimicrobials with therapeutic potential. Journal of Antimicrobial Chemotherapy. 2017; doi: 10.1093/jac/dkx147.

Boyd, D. A., L. F. Mataseje, R. Davidson, J. A. Delport, J. Fuller, L. Hoang, B. Lefebvre, P. Levett, D. L. Roscoe, B. M. Willey, M. R. Mulvey.  Enterobacter cloacae complex isolates harboring blaNMC-A or blaIMI-type class A carbapenemase genes on novel chromosomal integrative elements and plasmids. Antimicrobial Agents and Chemotherapy. 2017; 61: pii: e02578-16. doi: 10.1128/AAC.02578-16.

Demczuk, W., Sidhu, S., Unemo, M., Whiley, D. M., Allen, V. G., Dillon, J. R., Cole, M., Seah, C., Trembizki, E., Trees, D. L., Kersh, E.N., Abrams, A. J., de Vries, H. J. C., van Dam, A. P., Medina, I., Bharat, A., Mulvey, M. R., Van Domselaar, G., Martin, I. Neisseria gonorrhoeae Sequence Typing for Antimicrobial Resistance (NG-STAR): a novel antimicrobial resistance multilocus typing scheme for tracking the global dissemination of N. gonorrhoeae strains. Journal of Clinical Microbiology 2017; 55: 14541468.

Eyre, D. W., D. De Silva, K. Cole, J. Peters, M. J. Cole, Y. H. Grad, W. Demczuk, I. Martin, M. R. Mulvey, D. W. Crook, A. S. Walker, T. E. A. Peto, J. Paul. Whole genome sequencing to predict antibiotic minimum inhibitory concentrations for Neisseria gonorrhoeae. Journal of Antimicrobial Chemotherapy 2017; doi: 10.1093/jac/dkx067.

Edirmanasinghe, R., R. Finley, E. J. Parmley, B. P. Avery, C. Carson, S. Bekal, G.  Golding, and M. R. Mulvey. A Whole Genome Sequencing Approach to Study Cefoxitin-Resistant Salmonella enterica serovar Heidelberg from Various Sources. Antimicrobial Agents and Chemotherapy 2017; 61: doi: 10.1128/AAC.01919-16.

Demczuk, W. H. B., I. Martin, L. Hoang, P. Van Caeseele, B. Lefebvre, G. Horsman, D. Haldane, J. Gubbay, S. Ratnam, G. German, J. Daley Bernier, L. Strudwick, A. McGeer, G. G. Zhanel, G. Van Domselaar, M. Graham, M. R. Mulvey. Phylogenetic analysis of emergent Streptococcus pneumoniae serotype 22F causing invasive pneumococcal disease using whole genome sequencing. PLoS One 2017; 12:e0178040. doi: 10.1371/journal.pone.0178040.

Ellington, M. J., O. Ekelund, F. M. Aarestrup, R. Canton, M. Doumith, C. Giske, H. Grundman, H. Hasman, M. T. Holden, K. L. Hopkins, J. Iredell, G. Kahlmeter, C. U. Köser, A. MacGowan, D. Mevius, M. Mulvey, T. Naas, T. Peto, J. M. Rolain, Ø. Samuelsen, N. Woodford.  The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee. Journal of Clinical Microbiology 2017; 23:2-22.

Walkty, A., J. A. Karlowsky, H. J. Adam, P. Lagace-Wiens, M. Baxter, M. R. Mulvey, M. McCracken, S. Poutanen, D. Roscoe and G. G. Zhanel. Frequency of MCR-1-mediated colistin resistance among Escherichia coli clinical isolates obtained from patients in Canadian hospitals (CANWARD 2008-2015). Canadian Medical Association Journal 2016; 4:E641-E645.

Mulvey, M. R., L-P. Haraoui, and Y. Longtin.  Multiple Variants of Klebsiella pneumoniae Producing Carbapenemase in One Patient. New England Journal of Medicine 2016; 375:2408-2410.

Mataseje, L. F., K. Abdessekam, R. Mitchel, J. Vachon, E. Bryce, D. Roscoe, D. A. Boyd, J. Embree, K. Katz, P. Kibsey, A. Simor, G. Taylor, N. Turgeon, J. Langley, D. Gravel, K. Amaratunga, M. R. Mulvey. Canadian Nosocomial Infection Surveillance Program. Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae 2010-2014.  Antimicrobial Agents and Chemotherapy. 2016; 60:6787-6794.

Janecko, N., S.-L. Martz, B. P. Avery, D. Daignault, A. Desruisseau, D. Boyd, R. J. Irwin, M. R. Mulvey, and R. J. Reid-Smith. CRE found in imported seafood at retail in Canada. Emerging Infectious Diseases 2016; 22:1675-7.

Kim, J., X. Han, J. Bae, L. Chui, M. Louie, R. Finley, M. Mulvey, C. Ferrato, B. Jeon.  Prevalence of plasmid-mediated quinolone resistance (PMQR) genes in non-typhoidal Salmonella strains with resistance and reduced susceptibility to fluoroquinolone from human clinical cases in Alberta, Canada, from 2009 to 2013. Journal of Antimicrobial Chemotherapy 2016; 71-2988-90.

Bharat, A., I. Martin, W. Demczuk, V. Allen, D. Haldane, L. Hoang, and M. R. Mulvey.  Complete genome sequences of Neisseria gonorrhoeae with co-resistance to first line antimicrobials. Genome Announcements 2016; 4:e00966-16.

German, G. J., F. B. Jamieson, M. Gilmour, H. Almohri, J. Bullard, M. C. Domingo, J. Fuller, G. Girouard, D. Haldane, L. Hoang, P. N. Levett, J. Longtin, R. Melano, R. Needle, S. N. Patel, A. Rebbapragada, R. C. Reyes, and M. R. Mulvey. Interim recommendations for the reporting of extensively drug resistant and pan-drug resistant isolates of Enterobacteriaceae, Pseudomonas aeruginosa, Acinetobacter spp. and Stenotrophomonas maltophilia CCDR 2016: 42-4:91-97.

Jassem, A. N., N. Prystajecky, F. Marra, P. Kibsey, K. Tan, P. Umlandt, L. Janz, S. Champagne , B. Gamage, G. R. Golding, M. R. Mulvey, B. Henry, L. M. Hoang. Characterization of Clostridium difficile Strains in British Columbia, Canada: A Shift from NAP1 Majority (2008) to Novel Strain Types (2013) in One Region. Can J Infect Dis Med Microbiol. 2016; 2016:8207418.

Martin, I., P. Sawatzky, G. Liu, V. Allen, B. Lefebvre, L. Hoang, S. Drews, G. Horsman, J. Wylie, D. Haldane, R. Garceau, S. Ratnam, T. Wong, C. Archibald, M.R. Mulvey. Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance in Neisseria gonorrhoeae, Canada. Emerging Infectious Diseases 2016; 22:65-67.

Gray, A. P., R. Allard, R. Paré, T. Tannenbaum, B. Lefebvre, S. Levesque, M. Mulvey, L. Maalouf, S. Perna, Y. Longtin. Management of a hospital outbreak of extensively drug-resistant Acinetobacter baumannii using a multimodal intervention including daily chlorhexidine baths. J Hosp Infect 2016; 93:29–34.

Rahamathulla, M. P., B. N. Harish, L. Mataseje, and M. R. Mulvey.  Carbapenem resistance mechanisms among blood isolates of Klebsiella pneumoniae and Escherichia coli. African Journal of Microbiology Research 2016; 10:45-53.   20. Mulvey, M. R., L. Mataseje, J. Robertson, J. H. E. Nash, P. Boerlin, B. Toye, R. Irwin, R.G. Melano. Dissemination of mcr1colistin resistance gene. Lancet Infectious Diseases 2016; 16:147-149.

Peterson, S. W., N. Knox, G. Golding, S. Tyler J. Embree, F. Fleming, S. Fanella,  G. Van Domselaar, M. R. Mulvey, and  M. Graham. A study of the infant nasal microbiome development over the first year of life and in relation to their primary adult caregivers using cpn60 universal target (UT) as a phylogenetic marker. PLOS One 2016; 8: 11:e0152493. doi: 10.1371.

Demczuk, W., I. Martin, S. Peterson, A. Bharat, G. Van Domselaar, M. Graham, B. Lefebvre, V. Allen, L. Hoang, G. Tyrrell, G. Horsman, J. Wylie, D. Haldane, C. Archibald, T. Wong, M. Unemo, M. R. Mulvey. Genomic epidemiology and molecular resistance mechanisms of azithromycin resistant Neisseria gonorrhoeae in Canada from 1997 to 2014. Journal of Clinical Microbiology 2016; 54:1304-13.

Thoms-Rodriguez, C.-A., T. Mazzulli, N. Christian, B. M. Willey, D.A. Boyd, L. F.  Mataseje, M. R. Mulvey, C.D. Christie, A.M. Nicholson. New Delhi metallo-β-lactamase in Jamaica. The Journal of Infection in Developing Countries 2016; 10:183–187.

Simor, A. E., L. Pelude, G. Golding, R. Fernandes, E. Bryce, C. Frenette, D. Gravel, K. Katz, A. McGeer, M. Mulvey, S. Smith, K. Weiss, and the Canadian Nosocomial Infection Surveillance Program. Determinants of outcome in hospitalized patients with methicillin-resistant Staphylococcus aureus bloodstream infection: Results from National Surveillance in Canada, 2008-2012. Infection Control & Hospital Epidemiology 2016; 37:390-397.

Labbé, G., R. Edirmanasinghe, K. Ziebell, J. Nash, S. Bekal, J. Parmley, M. Mulvey, and R. Johnson. Complete Genome and Plasmid Sequences of Three Canadian Isolates of Salmonella enterica subsp. enterica Serovar Heidelberg from Human and Food Sources. Journal of Bacteriology 2016; 4:pii: e01526-15.
 
Mataseje, L., G. Peirano, D. Church, J. Conly, M. Mulvey, and J. Pitout. Colistin non-susceptible Pseudomonas aeruginosa ST654 with blaNDM-1 arrives in North America. Antimicrobial Agents and Chemotherapy 2016; 60:1794-1800.
 
Mangat, C., D. Boyd, N.  Janecko, S.-L. Martz, A. Deruisseau, M. Carpenter, R. Reid-Smith, and M. Mulvey.  Characterization of VCC-1, a novel Ambler Class A carbapenemase from Vibrio cholerae isolated from imported retail shrimp sold in Canada.  Antimicrobial Agents and Chemotherapy 2016; 60:1819-25.
 
Sekirov, I., M. Croxen, C. Ng, R. Azana, Y. Chang, L. Mataseje, D. Boyd, C. Mangat, B. Mack, M. Tadros, E. Brodkin, P. Kibsey, A. Stefanovic, S. Champagne, M. Mulvey, and L. Hoang. Epidemiologic and Genotypic Review of CarbapenemaseProducing Organisms in British Columbia between 2008 and 2014. Journal of Clinical Microbiology 2016; 54:317-27.   29. Bharat, A., I. Martin, G. G. Zhanel, M. R. Mulvey. In vitro potency and combination testing of antimicrobial agents against Neisseria gonorrhoeae. Journal of Infection and Chemotherapy 2015; 22:194-7.
 
Peterson, S. W., I. Martin, W. Demczuk, A. Bharat, L. Hoang, J. Wylie, V. Allen, B. Lefebvre, G. Tyrrell, G. Horsman, D. Haldane, R. Garceau, T. Wong, M. R. Mulvey. Molecular Assay for Detection of Ciprofloxacin Resistance in Neisseria gonorrhoeae Isolates from Cultures and Clinical Nucleic Acid Amplification Test Specimens. Journal of Clinical Microbiology 2015; 53:3606-8.
 
Lefebvre, B.,S. Lévesque, A.-M. Bourgault, M. R. Mulvey, L. Mataseje, D. Boyd, F. Doualla-Bell, C. Tremblay. Carbapenem Non-Susceptible Enterobacteriaceae in Quebec, Canada: Results of a Laboratory Surveillance Program (2010-2012). PLOS One 2015; 10:e0125076.
 
Peterson, S. W., I. Martin, W. Demczuk, A. Bharat, L. Hoang, J. Wylie, V. Allen, B. Lefebvre, G. Tyrrell, G. Horsman, D. Haldane, R. Garceau,  T. Wong, M. R. Mulvey. Molecular assay for the detection of genetic markers associated with decreased susceptibility to cephalosporins in Neisseria gonorrhoeae. Journal of Clinical Microbiology 2015; 53:2042-8.
 
Bharat, A., W. Demczuk, I. Martin, and M. R. Mulvey.  The effect of variants of penicillin-binding protein 2 on Cephalosporin and Carbapenem susceptibilities in Neisseria gonorrhoeae. Antimicrobial Agents and Chemotherapy 2015; 59:5003-6.
 
Le Saux, N., D. Gravel, M. Mulvey, D. Moore, J. Langley, S. Richardson, C. Quach, K. Baekyung Choi, M. Miller, K. Katz and the Canadian Nosocomial Infection Surveillance Program. Healthcare Associated Clostridium difficile Infections and Strain Diversity in Pediatric Hospitals in the Canadian Nosocomial Infection Surveillance Program: 2007-2011. Journal of the Pediatric Infectious Diseases Society 2015; 4:e151-4.
 
Fawley, W. N., D. MacCannell, C.W. Knetsch, C. Harmanus, T. Du, M. R. Mulvey, E. J. Kuijper, M. H. Wilcox. Development and Validation of an Internationally-Standardized, High-Resolution Capillary gel-based electrophoresis PCR-Ribotyping Protocol for Clostridium difficile. PLOS One 2015; 10:e0118150.
 
Quesada-Gómez, C., D. López-Uneña, L. Acuña-Amador, M. Villalobos-Zúñiga, T. Du, R. Freire, C. Guzmán-Verri, M. del Mar Gamboa-Coronado, T. Lawley, E. Moreno, M. Mulvey, G. A. de Castro Brito, E. Rodríguez-Cavallini, C. Rodríguez, and E. Chaves- Olarte. Emergence of an outbreak-associated Clostridium difficile variant with increased virulence. Journal of Clinical Microbiology 2015; 53:1216-1226.
 
Demczuk, W., T. Lynch, I. Martin, G. Van Domselaar, M. Graham, A. Bharat, V. Allen, L. Hoang, B. Lefebvre, G. Tyrrell, G. Horsman, D. Haldane, R. Garceau, J. Wylie, T. Wong, M. R. Mulvey. Whole-Genome Phylogenomic Heterogeneity of Neisseria gonorrhoeae Isolates with Decreased Cephalosporin Susceptibility Collected in Canada between 1989 and 2013. Journal of Clinical Microbiology 2015; 53:191-200.
 
Chong, P. S. McCorrister, M. Unger, D. Boyd, M. Mulvey, G. Westmacott. MALDI-TOF MS Detection of Carbapenemase activity in Clinical Isolates of Enterobacteriaceae spp., Pseudomonas aeruginosa, and Acinetobacter baumanii compared against the Carba-NP assay. Journal of Microbial Methods 2015; 111C:21-23.
 
Martin, I., P. Sawatzky, G. Liu, M. R. Mulvey. Antimicrobial resistance to Neisseria gonorrhoeae in Canada: 2013. Canadian Communicable Disease Reports 2015; 41-02.
 
Walkty, A., M. Gilmour, P. Simner, J. M. Embil, D. Boyd, M. Mulvey, J. Karlowsky. Isolation of multiple carbapenemaseproducing Gram-negative bacilli from a patient recently hospitalized in Nigeria. Diagnostic Microbiology and Infectious Diseases 2015; 81:296-8.
 
Boyd, D., G. Taylor, J. Fuller, E. Bryce, J. Embree, D. Gravel , K. Katz, P. Kibsey, M. Kuhn, J. Langley, L. Mataseje, R. Mitchell, D. Roscoe , A. Simor, E. Thomas, N. Turgeon, M. Mulvey, on behalf of the Canadian Nosocomial Infection Surveillance Program. Complete sequence of four multidrug resistant MOBQ1 plasmids harboring blaGES-5 isolated from Escherichia coli and Serratia marcescens persisting in a hospital in Canada. Microbial Drug Resistance 2014; 21:253-60.
 
Gravel, D., C.P. Archibald, L. Pelude, M. Mulvey, G. Golding on behalf of the Canadian Nosocomial Infection Surveillance Program. Antimicrobial resistance surveillance in Canadian hospitals, 2007−2012. Canadian Communicable Disease Reports 2014; 40:S2.
 
Sepehri, S., G. Poliquin, N. Alfattoh, D. Boyd, M. Mulvey, A. Denisuik, S. Fanella, J. Karlowsky, A. Walkty. Osteomyelitis due to multiple carbapenemase-producing Gram-negative bacteria: The first case report of a GES-13-producing Pseudomonas aeruginosa isolate in Canada. Can J Infect Dis Med Microbiol 2014; 25:229-231.
 
Moya-Torres, A., M. R. Mulvey, A. Kumar, I. J. Oresnik, and A. K. C. Brassinga. Lack of OmpF, but not OmpC, Contributes to Increased Antibiotic Resistance in Serratia marcescens. Microbiology 2014; 160:1882-1892.
 
Le Saux, N., D. Gravel, M. R. Mulvey, J. Dennis, A. Yasseen, N. Barrowman, J. Bowes. Pediatric Clostridium difficile Infection: 6 Year Active Surveillance in a Defined Patient Population. Infection Control and Hospital Epidemiology 2014; 35:904-6.
 
Tijet, N., D. Boyd, S. Patel, M. Mulvey, and R. Melano. Further Proofs of Concept for the Carba NP Test. Antimicrobial Agents and Chemotherapy 2014; 58:1270.
 
Chong, P. M., T. Lynch, S. McCorrister, P. Kibsey, M. Miller, D. Gravel, G.R. Westmacott, M. R. Mulvey, and the Canadian Nosocomial Infection Surveillance Program (CNISP). Proteomic analysis of a NAP1 Clostridium difficile clinical isolate resistant to metronidazole. PLOS ONE 2014; 9:e82622.
 
Mataseje, L., D. Boyd, B. Lefebvre, E. Bryce, J. Embree, D. Gravel, K. Katz, P. Kibsey, M. Kuhn, J. Langley, R. Mitchell, D. Roscoe, A. Simor, G. Taylor, E. Thomas, N. Turgeon, M. Mulvey. Complete sequences of a novel blaNDM-1- harbouring plasmid from Providencia rettgeri and an FII-type plasmid from Klebsiella pneumoniae identified in Canada. Journal of Antimicrobial Chemotherapy 2014; 69:637-642.
 
Schwartz, K. L., I. Darwish, S.E. Richardson, M. R. Mulvey and N. Thampi. Severe clinical outcome is uncommon in Clostridium difficile infection in children: A retrospective cohort study. BMC Pediatrics 2014;14:28.
 
Mataseje, L., D. Boyd, J. Delport, L. Hoang, S. Imperial, B. Lefebvre, M. Kuhn, P. Van Caeseele, B. Willey, M. Mulvey. Serratia marcescens harbouring SME-type class A carbapenemases in Canada and the presence of blaSME on a novel genomic island, SmarGI1-1. Journal of Antimicrobial Chemotherapy 2014; 69:1825-1829.
 
Tijet, N., D. Boyd, S. Patel, M. Mulvey, and R. Melano. Evaluation of the Carba NP test for rapid detection of carbapenemase-producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother 2013; 57:4578-80.
 
Macedo-Viñas, M., J. Conly, P. Francois, R. Aschbacher, D. S. Blanc, G. Coombs, G. Daikos, B. Dhawan, J. Empel, J. Etienne, A. M. S. Figueiredo, G. Golding and CNISP, L. Han, H. B. Kim, R. Köck, A. Larsen, F. Layer, J. Lo, T. Maeda, M. Mulvey, A. Pantosti, T. Saga, J. Schrenzel, A. Simor, R. Skov, M. Van Rijen, H. Wang, Z. Zakaria, S. Harbarth. Antibiotic susceptibility and molecular epidemiology of Panton-Valentine leukocidin-positive meticillin-resistant Staphylococcus aureus: An international survey. Journal of Global Antimicrobial Resistance 2013; Res. DOI: 10.1016/j.jgar.
 
Mather, A. E., S. W. J. Reid, D. J. Maskell, J. Parkhill, M. C. Fookes, S. R. Harris, D. J. Brown, J. E. Coia, M. R. Mulvey, M. W. Gilmour, L. Petrovska, E. de Pinna, M. Kuroda, M. Akiba, H. Izumiya, T. R. Connor, M. A. Suchard, P. Lemey, D. J. Mellor, D. T. Haydon, N. R. Thomson. Distinguishable epidemics of multidrug-resistant Salmonella Typhimurium DT104 in different hosts. Science 2013; 341:1514-7.
 
Heslop, O. D., K. Roye-Green, K. Coard and M. Mulvey. A unique strain of community-acquired Clostridium difficile in severe complicated infection and death of a young adult. BMC Infectious Diseases 2013; 13:299.
 
McDonald, R., G. Golding, J. Irvine, M. Graham, S. Tyler, M. Mulvey, and P. Levett. Draft genome sequence of Streptococcus pyogenes strain 06BA18369, a human pathogen associated with skin and soft tissue infections in northern Canada. Genome Announcements 2013; 1:e00387-13.

McArthur, A., N. Waglechner, F. Nizam, A. Yan, M. Azad, A. Baylay, K. Bhullar, M. Canova, G. De Pascale, L. Ejim, L. Kalan, A. King, K. Koteva, M. Morar, M. Mulvey, J. O'Brien, A. Pawlowski, L. Piddock, P. Spanogiannopoulos, A. Sutherland, I. Tang, P. Taylor, M. Thaker, W. Wang, M. Yan, T. Yu, and G. Wright. The Comprehensive Antibiotic Resistance Database. Antimicrobial Agents and Chemotherapy 2013; 57: 3348-57.
 
Haraoui, L.-P., S. Lévesque, B. Lefebvre, R. Blanchette, M. Tomkinson, L. Mataseje, M. R. Mulvey, and M. Miller. Polyclonal Outbreak of KPC-3-producing Enterobacter cloacae at a Single Hospital in Montréal, Canada. Journal of Clinical Microbiology 2013; 51:2406-08.
 
Mulvey, M. R., R. Finley, V. Allen, L. Ang, S. Bekal, S. El Bailey, D. Haldane, L. Hoang, G. Horsman, M. Louie, L. Robberts, J. Wylie, M. McCracken, S. Langner, R. Ahmed, H. Tabor, and M. Gilmour. Emergence of Multidrug Resistant Salmonella enterica serotype 4,[5],12:i:- involving Human Cases in Canada: Results from the Canadian Integrated Program on Antimicrobial Resistance Surveillance (CIPARS), 2003-2010. Journal of Antimicrobial Chemotherapy 2013; 68:1982-6.
 
Mulvey, M. R., D. A. Boyd, R. Finley, K. Fakharuddin, S. Langner, V. Allen, L. Ang, S. Bekal, S. El Bailey, D. Haldane, L. Hoang, G. Horsman, M. Louis, L. Robberts, and J. Wylie. Ciprofloxacin-Resistant Salmonella enterica Serovar Kentucky in Canada. Emerging Infectious Diseases 2013; 19: 999-1001.
 
McCracken, M., A. Wong, R. Mitchell, D. Gravel, J. Conly, J. Embil, L. Johnston, A. Matlow, D. Ormiston, A. Simor, S. Smith, T. Du, R. Hizon, M. R. Mulvey. The Molecular Epidemiology of Vancomycin-Resistant Enterococcal Bacteraemia: Results from the Canadian Nosocomial Infection Surveillance Program: 1999-2009. Journal of Antimicrobial Chemotherapy 2013; 68:1505-9.
 
Lagacé-Wiens, P., H. Adam, D. E. Low, J. Blondeau, M. DeCorby, A. Denisuik, K. Nichol, A. Walkty, J. Karlowsky, M. Mulvey, D. Hoban, G. G. Zhanel. Trends in Antibiotic Resistance over Time Among Pathogens from Canadian Hospitals over Time: Results of the CANWARD Study 2007-2011. Journal of Antimicrobial Chemotherapy 2013; 68: Sup 1: 23-29.
 
Mataseje, L. F., D. A. Boyd, L. Hoang, M. Imperial, B. Lefebvre, M. Miller, S. M. Poutanen, D. Roscoe, B. M. Willey, and M. R. Mulvey. Importation of OXA-48-like-producing carbapenemases in Canada. Emerging Infectious Diseases 2013; 19:157-60.
 
Denisuik, A., P. Lagacé-Wiens, J. Pitout, M. Mulvey, P. Simner, F. Tailor, J. Karlowsky, D. Hoban, G. G. Zhanel. Molecular Epidemiology of Extended-spectrum β-lactamase-, AmpC β-lactamase-, and Carbapenemase-producing Escherichia coli and Klebsiella pneumoniae Isolated from Canadian Hospitals over a 5 Year Period: CANWARD 2007-2011. Journal of Antimicrobial Chemotherapy 2013; 68:Sup 1: 57-65.
 
Quesada-Gómez, C., M. R. Mulvey, P. Vargas, M. del Mar Gamboa-Coronado, C. Rodríguez, E. Rodríguez-Cavillini. Isolation of a toxigenic and clinical genotype of Clostridium difficile in retail meats in Costa Rica. Journal of Food Protection 2013; 76:34851.
 
Leung, V., V. G. Loo, C. Frenette, M. C. Domingo, A. M. Bourgault, M. R. Mulvey, H. G. Robson. First Canadian outbreak of Enterobacteriaceae-expressing Klebsiella pneumoniae carbapenemase type 3. Can J Infect Dis Med Microbiol 2012; 23:117-120.
 
Lynch, T., P. Chong, J. Zhang, R. Hizon, T. Du, M. R. Graham, D. R. Beniac, T. F. Booth, P. Kibsey, M. Miller, D. Gravel, M. R. Mulvey, Canadian Nosocomial Infection Surveillance Program (CNISP). Characterization of a Stable, Metronidazole-Resistant Clostridium difficile Clinical Isolate. PLOS One 2012; 8: e53757.
 
Boyd, D. A. and M. R. Mulvey. The VanE operon in E. faecalis N00-410 is found on a putative integrative conjugative element, Tn6202. Journal of Antimicrobial Chemotherapy 2012; 68:294-9.
 
Golding, G., N. Persaud, P. N. Levett, R. R. McDonald, J. Irvine, M. Nsungu, S. Woods, M. Khan, L. Mataseje, M. R. Mulvey, and the Northern Antibiotic Resistance Partnership. Characterization of Escherichia coli Urinary Tract Infection Isolates in Remote Northern Saskatchewan Communities: the Northern Antibiotic Resistance Partnership (NARP). Diagnostic Microbiology and Infectious Disease 2012; 74:242-247.
 
Doublet, B., D. Boyd, G. Douard, K. Praud, A. Cloeckaert, and M. R. Mulvey. Complete nucleotide sequence of multidrug- resistance IncA/C plasmid pR55 from Klebsiella pneumoniae isolated in 1969. Journal of Antimicrobial Chemotherapy 2012; 67:2354-2360.